Form 4: BRADY CORP Executive Sells Shares After Option Exercise
Insider Transaction Report
BRADY CORP's General Counsel and Corporate Secretary, Andrew Gorman, exercised stock options and subsequently sold a total of 12,528 shares of Class A Common Stock.
Summary
- Andrew Gorman, General Counsel and Corporate Secretary of BRADY CORP, reported transactions involving the company's Class A Common Stock.
- On November 25, 2025, Gorman exercised stock options to acquire 6,469 shares of Class A Common Stock at an exercise price of $49.79 per share.
- Concurrently, on November 25, 2025, Gorman sold these 6,469 shares at a price of $80.01 per share.
- Also on November 25, 2025, Gorman exercised additional stock options to acquire 6,059 shares of Class A Common Stock at an exercise price of $43.50 per share.
- Immediately following, these 6,059 shares were sold at a price of $80.01 per share.
- The total number of shares acquired through option exercise and subsequently sold was 12,528.
- Following these transactions, Andrew Gorman's direct beneficial ownership of Class A Common Stock is 14,153 shares.
- The transactions were made pursuant to a Rule 10b5-1 pre-arranged trading plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, these transactions are routine for executives monetizing vested options and were conducted under a pre-arranged 10b5-1 plan, indicating transparency and a lack of new, negative information.
Positives
- The executive realized a significant gain from the exercise of stock options and subsequent sale of shares, totaling approximately $416,708.27.
- The transactions were conducted under a Rule 10b5-1 plan, indicating a pre-scheduled and transparent approach to insider trading.
Negatives
- The sale of 12,528 shares by a key executive could be perceived as a reduction in insider confidence, although it is a common practice for executives to monetize vested options.
Risks
- While these transactions are routine for executives monetizing vested options, significant insider selling, even under a 10b5-1 plan, can sometimes be interpreted negatively by the market if not understood in context.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This is a routine insider transaction filing (Form 4) and does not provide specific insights into broader industry trends or competitive landscape. It reflects an executive's personal financial planning related to their compensation.
Stakeholder Impact
- Shareholders: May observe a reduction in direct insider ownership, but the 10b5-1 plan context suggests it's a planned compensation event rather than a signal of declining confidence.
- Employees: No direct impact indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 11/25/2025 | Date of all reported transactions (option exercises and share sales). |
| 11/26/2025 | Date the Form 4 filing was signed. |
Recommendation
holdThis Form 4 filing details routine insider transactions (option exercises and sales) conducted under a pre-arranged 10b5-1 plan. Such transactions are common for executive compensation and typically do not provide new fundamental information about the company's operational performance or future prospects that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, as the filing itself does not present a compelling reason to buy or sell based solely on this information.
Keywords
BRADY CORP, BRC, Insider Trading, Form 4, Stock Options, Executive Compensation, Rule 10b5-1, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.